Filing Details
- Accession Number:
- 0000950117-10-000388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-29 13:00:00
- Reporting Period:
- 2010-03-25
- Filing Date:
- 2010-03-29
- Accepted Time:
- 2010-03-29 14:38:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 50710 | Javelin Pharmaceuticals Inc | JAV | Pharmaceutical Preparations (2834) | 880471759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311634 | B Daniel Carr | C/O Javelin Pharmaceuticals, Inc. 125 Cambridgepark Drive Cambridge MA 02140 | President And Cmo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-25 | 5,307 | $1.07 | 160,601 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-25 | 4,700 | $1.35 | 155,901 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-03-26 | 767 | $1.07 | 156,668 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-26 | 700 | $1.35 | 155,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2010-03-25 | 5,307 | $0.00 | 5,307 | $1.07 |
| Common Stock | Stock Option | Disposition | 2010-03-26 | 767 | $0.00 | 767 | $1.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,593 | 2019-01-23 | No | 4 | M | Direct | |
| 89,826 | 2019-01-23 | No | 4 | M | Direct |
Footnotes
- Includes (i) 31,246 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer's Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.
- Granted under the Issuer's Amended and Restated 2005 Stock Incentive Plan.
- Vesting in three equal annual installments beginning after the first year.
Billionaire Hedge Funds
